BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Salehi-Rad R, Li R, Paul MK, et al. The biology of lung cancer: development of more effective methods for prevention, diagnosis, and treatment. Clin Chest Med. 2020;41(1):25–38.
   PubMed Web of Science ®Google Scholar
• Bria E, Milella M, Cuppone F, et al. Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis. Ann Oncol. 2011;22(10):2277–2285.
   PubMed Web of Science ®Google Scholar
• Schvartzman J-M, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer. 2010;10(2):102–115.
   PubMed Web of Science ®Google Scholar
• Pfau SJ, Amon A. Chromosomal instability and aneuploidy in cancer: from yeast to man: ‘Exploring aneuploidy: the significance of chromosomal imbalance’ review series. EMBO Rep. 2012;13(6):515–527.
   PubMed Web of Science ®Google Scholar
• McGranahan N, Burrell RA, Endesfelder D, et al. Cancer chromosomal instability: therapeutic and diagnostic challenges: ‘Exploring aneuploidy: the significance of chromosomal imbalance’review series. EMBO Rep. 2012;13(6):528–538.
   PubMed Web of Science ®Google Scholar
• Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 1998;392(6673):300–303.
   PubMed Web of Science ®Google Scholar
• Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005;5(10):773–785.
   PubMed Web of Science ®Google Scholar
• Davenport JW, Fernandes ER, Harris LD, et al. The mouse mitotic checkpoint gene bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner. Genomics. 1999;55(1):113–117.
   PubMed Web of Science ®Google Scholar
• Scintu M, Vitale R, Prencipe M, et al. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett. 2007;254(2):298–307.
   PubMed Web of Science ®Google Scholar
• Ma Q, Liu Y, Shang L, et al. The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma. Oncol Rep. 2017;38(6):3367–3375.
   PubMed Web of Science ®Google Scholar
• Dong S, Huang F, Zhang H, et al. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma. Biosci Rep. 2019;39(2). DOI:10.1042/BSR20182306.
   Google Scholar
• Qiu J, Zhang S, Wang P, et al. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. Cancer Med. 2020;9(21):8159–8172.
   PubMed Web of Science ®Google Scholar
• Tian J-H, Mu L-J, Wang M-Y, et al. BUB1B promotes proliferation of prostate cancer via transcriptional regulation of MELK. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2020;20(9):1140–1146.
   PubMed Web of Science ®Google Scholar
• Darnell JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer. 2002;2(10):740–749.
   PubMed Web of Science ®Google Scholar
• Bushweller JH. Targeting transcription factors in cancer—from undruggable to reality. Nat Rev Cancer. 2019;19(11):611–624.
   PubMed Web of Science ®Google Scholar
• Kendall J, Liu Q, Bakleh A, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Nat Acad Sci. 2007;104(42):16663–16668.
   PubMed Web of Science ®Google Scholar
• Wang G, Bai X, Jiang G, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021;12(1):30–43.
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang Y, Deng J, et al. Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis. Bioengineered. 2021 Dec;12(1):6251–6263.
   PubMed Web of Science ®Google Scholar
• Zois CE, Favaro E, Harris AL. Glycogen metabolism in cancer. Biochem Pharmacol. 2014;92(1):3–11.
   PubMed Web of Science ®Google Scholar
• Zois CE, Harris AL. Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy. J Mol Med. 2016;94(2):137–154.
   PubMed Web of Science ®Google Scholar
• Luo J, Wang H, Wang L, et al. Long noncoding RNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in lung adenocarcinoma via repressing E2F1-mediated transcription of GLUT1. 2021;25:11–24 .
   Google Scholar
• Contat C, Ancey P-B, Zangger N, et al. Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth. Elife. 2020;9:e53618.
   PubMed Web of Science ®Google Scholar
• Yu C, Hou L, Cui H, et al. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma. Future Oncol. 2018;14(24):2483–2492.
   PubMed Web of Science ®Google Scholar
• Guo C-Y, Zhu Q, Tou -F-F, et al. The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma. BMC Cancer. 2019;19(1):289.
   PubMedGoogle Scholar
• Sun T, Du B, Diao Y, et al. ATAD2 expression increases [18F] Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway. BMB Rep. 2019;52(7):457.
   PubMed Web of Science ®Google Scholar
• Xiong L, Bai Y, Zhu M, et al. Predictive value of CCNB1, BUB1B and TTK in the progression and prognosis of lung adenocarcinoma. 2020; 2020060126
   Google Scholar
• Franco-Zorrilla JM, López-Vidriero I, Carrasco JL, et al. DNA-binding specificities of plant transcription factors and their potential to define target genes. Proc Nat Acad Sci. 2014;111(6):2367–2372.
   PubMed Web of Science ®Google Scholar
• Yu H, Luscombe NM, Qian J, et al. Genomic analysis of gene expression relationships in transcriptional regulatory networks. Trends Genet. 2003;19(8):422–427.
   PubMed Web of Science ®Google Scholar
• Myslinski E, Gerard M-A, Krol A, et al. Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143. Nucleic Acids Res. 2007;35(10):3453–3464.
   PubMed Web of Science ®Google Scholar
• Wei S, Wang L, Zhang L, et al. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway. Tumor Biol. 2016;37(9):12813–12821.
   PubMedGoogle Scholar
• Sadłecki P, Grabiec M, Grzanka D, et al. Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers. J Ovarian Res. 2019;12(1):23.
   PubMedGoogle Scholar
• Paek AR, Lee CH, You HJ. A role of zinc‐finger protein 143 for cancer cell migration and invasion through ZEB1 and E‐cadherin in colon cancer cells. Mol Carcinog. 2014;53(S1):E161–E168.
   PubMedGoogle Scholar
• Zhang L, Huo Q, Ge C, et al. ZNF143-mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma. Cancer Res. 2020;80(12):2599–2611.
   PubMed Web of Science ®Google Scholar